Form 4: Xilio Therapeutics CEO Rene Russo Granted Stock Options
SEC Form 4 Filing
Rene Russo, CEO of Xilio Therapeutics, was granted stock options to purchase 474,000 shares of common stock on May 1, 2024.
Summary
- Rene Russo, the President and CEO of Xilio Therapeutics, Inc., was granted stock options on May 1, 2024.
- The options allow Russo to purchase 474,000 shares of Xilio Therapeutics' common stock at an exercise price of $1.08 per share.
- The options vest monthly from June 1, 2024, until May 1, 2028.
- The options expire on April 30, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders.
Positives
- The granting of stock options to the CEO aligns their interests with those of the shareholders.
- The vesting schedule incentivizes long-term performance and commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common practice in the biotechnology industry to incentivize and retain key executives.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotech industry, often used to align management's interests with shareholder value.
- Comparable companies like Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their executive compensation strategy.
- The vesting schedule and exercise price are typical for similar grants in the industry, designed to incentivize long-term performance.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CEO to drive long-term value.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of the transaction: Stock options granted to Rene Russo. |
| 06/01/2024 | Vesting start date: 1/48th of the shares begin to vest. |
| 05/01/2028 | End of vesting period: Stock options vest in equal monthly installments until this date. |
| 04/30/2034 | Expiration date of the stock options. |
| 05/03/2024 | Date of the form's signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.